🕵️ Novabridge Biosciences ($NBP)
SEC insider & ownership activity, last 12 months · CIK 1778016 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
🚨 2 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Insider flow
1 buyer, value withheld pending verification (1 lots) · 3 sellers, $148K (6 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Cao Sean Wuxiong | 0 | – | 2 | $122K | Sep 9, 2026 |
| Xu Cong Claire | 0 | – | 3 | $20K | Aug 31, 2026 |
| Dennis Phillip Andrew | 0 | – | 1 | $6K | Jun 18, 2026 |
| Hagler Mark Arnold | 1 | value withheld pending verification | 0 | – | Apr 24, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Everest Medicines Limited | 16.1% | 13D | Aug 5, 2025 | filing ↗ | |
| Wei Fu | 11.5% | 13D | Jan 29, 2026 | filing ↗ | |
| C-Bridge Capital GP, Ltd. | 8.8% | 13D | Jan 29, 2026 | filing ↗ | |
| C-Bridge Healthcare Fund II, L.P. | 5.3% | 13D | Jan 29, 2026 | filing ↗ | |
| C-Bridge Healthcare Fund GP II, L.P. | 5.3% | 13D | Jan 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Cao Sean Wuxiong | $79K | Sep 9, 2026 | filing ↗ |
| Cao Sean Wuxiong | $19K | May 14, 2026 | filing ↗ |
| Dennis Phillip Andrew | $10K | Mar 18, 2026 | filing ↗ |
| Joseph W. Skelton | $520K | Jan 2, 2026 | filing ↗ |
| Dennis Phillip Andrew | $15K | Dec 18, 2025 | filing ↗ |
Material events (8-K)
No 8-K filings in the last 12 months.